Abstract
Recently, advances in the development of portable biosensors for detection of cardiac Troponin I (cTnI) have been made, yet complex recognition elements, expensive preparation costs, and limitations in quantification have hampered their widespread application. In present study, we have developed a portable biosensor for on-site detection of cTnI, taking advantage of the signal amplification function of a DNA walker and a low-cost personal glucose meter (PGM) and developed a new time-saving method for protein DNA coupling. In the presence of the target, the walking particle (WB) rolls rapidly along the surface of the track particle (TB), releasing a short DNA fragment labeled with invertase. Invertase catalyzes the hydrolysis of sucrose to glucose, which is quantified using a PGM. DNA Walker achieves recycling by regulating DNA stepwise movement by DNA nicking endonuclease (Nb.BbvCI). Under optimal conditions, the limit of detection (LOD) for cTnI was 0.001 ng/mL (S/N = 3), which is below the current acute myocardial infarction (AMI) detection standard (40 pg/mL). In addition, we validated the versatility of the platform by quantifying the RNA. With these features, the Recycling Walker-cTnI-Glucometer (RWCG) strategy was eventually applied to clinical serum, which indicates their important potential for early clinical diagnosis and treatment and trace biological sample detection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.